UCB announces positive results from GEMZ Phase 3 study of fenfluramine in CDKL5 deficiency disorder Jyoti Kumari30 Jun 2025 11:15 AM IST ATLANTA: UCB, a global biopharmaceutical company, today announced that the Phase 3 study investigating the safety and efficacy of adjunctive...
Full Inspection of Packaged Water Units in Maharashtra Mandatory, Says FSSAI Jyoti Kumari30 Jun 2025 9:30 AM ISTThane: The Food Safety and Standards Authority of India has ordered a "100 per cent inspection" of packaged drinking water facilities across...
AstraZeneca expands Global Hub in Bangalore with Rs 166 crore investment Ruchika Sharma29 Jun 2025 4:30 PM ISTThe hub is designed to achieve LEED Platinum certification and is currently powered by 75% green energy.
Merck Enflonsia wins ACIP backing for RSV protection in infants under 8 months Ruchika Sharma29 Jun 2025 1:15 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced the U.S. Centers for Disease Control and Prevention (CDC)...
Intas Gets SEC Nod to Import, Market Anti-Cancer Drug Serplulimab, Phase IV Trial Mandated Dr. Divya Colin29 Jun 2025 1:00 PM ISTNew Delhi: Intas Pharmaceutical has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
USFDA approves label updates for Bristol Myers Squibb 2 CAR T cell therapies Ruchika Sharma29 Jun 2025 12:30 PM ISTPrinceton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has approved label updates for both of its CAR T...
Bayer Eylea 8 mg with extended 6-month treatment interval approved in EU for retinal diseases Ruchika Sharma29 Jun 2025 11:00 AM ISTBerlin: Bayer has received approval from the European Commission (EC) for a label extension in the European Union (EU) for Eylea 8 mg...
Abbott Gets SEC Nod to Market Chlordiazepoxide Tablets for Anxiety, Alcohol Withdrawal Dr. Divya Colin28 Jun 2025 7:44 PM ISTNew Delhi: Abbott Healthcare has received approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control...
Safety first: Aurobindo recalls discolored pain relieving drug in US Ruchika Sharma28 Jun 2025 3:30 PM ISTU.S.: In a swift move to protect consumers, Aurobindo Pharma's U.S. unit is recalling more than 4,600 bottles of its pain reliever, Acetaminophen...
USFDA lifts Risk Evaluation and Mitigation Strategies for CAR T cell therapies Ruchika Sharma28 Jun 2025 12:59 PM ISTThe U.S. Food and Drug Administration (USFDA) has announced that it has eliminated the Risk Evaluation and Mitigation Strategies (REMS) for currently...
USFDA issues 1 observation for Granules Pharma USA facility Ruchika Sharma28 Jun 2025 11:16 AM ISTHyderabad: Granules India has announced that the U.S. Food and Drug Administration (US FDA) has issued one 483 observation after a...
Akums Gets CDSCO Panel Nod for BE Study of Rizatriptan-Meloxicam FDC, Told to Revise Phase III Protocol Dr. Divya Colin27 Jun 2025 11:07 PM ISTNew Delhi: In response to the proposal presented by the Akums Drugs & Pharmaceuticals along with BE and Phase III clinical trial protocol of the...
